TRU 016: Clinical Trials

1 trial of TRU 016, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow TRU 016: new trials by email Literature Review of TRU 016 trials Research Report on TRU 016

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
TRU-016 and bendamustine, Bendamustine, 15 mg/kg TRU-016 and bendamustine - Chronic Lymphocytic Leukemia (CLL)
Phase 1 / Phase 2CompletedAptevo Therapeutics792010-09-012021-06-10

Conditions studied

Leukemia, Lymphocytic, Chronic, B-Cell (1)

Sponsors

Aptevo Therapeutics (1)

Countries

Austria (1)  ·  Germany (1)  ·  Poland (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Scott Stromatt, MD (1)